Xylem (XYL) – Research Analysts’ Recent Ratings Updates

Several analysts have recently updated their ratings and price targets for Xylem (NYSE: XYL):

  • 2/10/2018 – Xylem was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $81.00 price target on the stock. According to Zacks, “Xylem’s shares have outperformed the industry in three months’ time. The company reported robust fourth-quarter 2017 results. Quarterly adjusted earnings of 76 cents per share, exceeded the year-ago tally by 12%. The company believes improving wastewater transport, dewatering, gas, software & services and analytics business will continue to bolster its revenues in the quarters ahead. Moreover, stronger residential, commercial and industrial applications businesses would likely strengthen revenues going forward. Moreover, Xylem noted that addition of Pure Technologies and EmNet will enhance its competency. Profitability in the upcoming quarters is anticipated to improve on the back of stronger top-line growth and ongoing productivity initiatives. Increased free cash flow generation will likely be spent over dividend payouts, new capital-expenditure programs and debt repayment.”
  • 2/2/2018 – Xylem had its “buy” rating reaffirmed by analysts at BMO Capital Markets. They now have a $86.00 price target on the stock.
  • 2/2/2018 – Xylem had its “buy” rating reaffirmed by analysts at Seaport Global Securities. They now have a $83.00 price target on the stock.
  • 2/2/2018 – Xylem had its price target raised by analysts at Oppenheimer Holdings Inc. to $82.00. They now have an “outperform” rating on the stock.
  • 1/28/2018 – Xylem had its “hold” rating reaffirmed by analysts at Canaccord Genuity. They now have a $75.00 price target on the stock.
  • 1/26/2018 – Xylem had its “buy” rating reaffirmed by analysts at BMO Capital Markets. They now have a $83.00 price target on the stock.
  • 1/22/2018 – Xylem was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Over the last three months, Xylem's shares have outperformed the industry. The company believes robust semiconductor and industrial end-markets' demand will continue to drive its revenues in the quarters ahead, while greater operational efficacy will boost bottom-line results. Integration process of the Analytics and Sensus businesses is right on track and is expected to drive its Measurement and Control Solutions segment's performance in the upcoming quarters. Xylem also intends to fund strategic investment projects and boost shareholders' return on the back of increased cost savings. However, Xylem's stock looks overvalued compared to the industry. Moreover, we expect that headwinds such as a stronger U.S. dollar, supply chain challenges or unfavorable climatic conditions might weigh over the company's near-term results. Over the last 7 days, Zacks Consensus Estimate for the stock has remained unchanged for 2018.”
  • 1/21/2018 – Xylem was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $80.00 price target on the stock. According to Zacks, “Xylem’s shares have outperformed the industry in three months’ time. The company believes that robust semiconductor and industrial end-markets’ demand will continue to drive its revenues in the quarters ahead. In addition, greater operational efficacy will likely bolster the company’s near-term bottom-line results. Integration process of the Analytics and Sensus businesses is right on track and is expected to drive its Measurement and Control Solutions segment’s performance in the upcoming quarters. Xylem also intends to fund strategic investment projects and boost shareholders’ return on the back of increased cost savings. Over the last 60 days, Zacks Consensus Estimate for the stock moved north for 2018.”
  • 1/4/2018 – Xylem had its “buy” rating reaffirmed by analysts at Royal Bank of Canada. They now have a $80.00 price target on the stock.
  • 12/15/2017 – Xylem had its “buy” rating reaffirmed by analysts at Boenning Scattergood. They wrote, “We came away seeing the deal as a potential game-changer, creating an infrastructure diagnostics platform that is unprecedented in terms of product breadth, financial scale, channel bandwidth, and marketing heft, and positioning Xylem to transform what has long been a promising (yet frustratingly slow to develop) niche of the water market into a source of robust profitable growth and value creation. Competitors are already actively plotting evasive action, particularly on the pricing front, where there is a view that synergies could enable Xylem to accelerate growth by bringing down Pure’s infamously high pricing (historically an important selling point used successfully by competitors). Equally important, the deal creates a unique combination of diagnostics and metering that is well- timed given the market’s evolution from meter-based leak detection to standalone condition assessment solutions.””

Shares of Xylem Inc (NYSE:XYL) traded up $1.46 during midday trading on Monday, reaching $72.28. 398,569 shares of the company were exchanged, compared to its average volume of 1,100,708. The company has a market cap of $12,719.27, a price-to-earnings ratio of 39.28, a PEG ratio of 1.35 and a beta of 1.20. Xylem Inc has a 1-year low of $46.95 and a 1-year high of $76.81. The company has a current ratio of 1.88, a quick ratio of 1.41 and a debt-to-equity ratio of 0.87.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Thursday, February 1st. The industrial products company reported $0.76 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.76. The business had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.27 billion. Xylem had a net margin of 7.03% and a return on equity of 17.95%. The firm’s quarterly revenue was up 16.6% on a year-over-year basis. During the same quarter last year, the business earned $0.66 EPS. analysts predict that Xylem Inc will post 2.91 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 15th. Investors of record on Thursday, February 15th will be issued a $0.21 dividend. This represents a $0.84 dividend on an annualized basis and a yield of 1.16%. The ex-dividend date of this dividend is Wednesday, February 14th. This is a positive change from Xylem’s previous quarterly dividend of $0.18. Xylem’s dividend payout ratio (DPR) is 39.13%.

In other Xylem news, Director Steven R. Loranger sold 17,139 shares of the firm’s stock in a transaction that occurred on Wednesday, December 20th. The shares were sold at an average price of $68.10, for a total transaction of $1,167,165.90. Following the completion of the transaction, the director now owns 26,150 shares in the company, valued at approximately $1,780,815. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Steven R. Loranger sold 47,712 shares of the firm’s stock in a transaction that occurred on Monday, December 18th. The stock was sold at an average price of $68.10, for a total transaction of $3,249,187.20. Following the transaction, the director now owns 68,843 shares of the company’s stock, valued at approximately $4,688,208.30. The disclosure for this sale can be found here. In the last quarter, insiders sold 67,507 shares of company stock valued at $4,596,445. 0.75% of the stock is owned by company insiders.

Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Receive News & Ratings for Xylem Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply